Cargando…

Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates

PURPOSE: To characterize the molecular, epidemiological, and resistance profiles of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) keratitis isolates. PATIENTS AND METHODS: We used a combination of standard microbiological techniques and DNA microarray analysis to characterize the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Jeffrey C, Durkee, Heather, Miller, Darlene, Maestre-Mesa, Jorge, Arboleda, Alejandro, Aguilar, Mariela C, Relhan, Nidhi, Flynn, Harry W, Amescua, Guillermo, Parel, Jean-Marie, Alfonso, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469469/
https://www.ncbi.nlm.nih.gov/pubmed/31043797
http://dx.doi.org/10.2147/IDR.S190245
_version_ 1783411643787509760
author Peterson, Jeffrey C
Durkee, Heather
Miller, Darlene
Maestre-Mesa, Jorge
Arboleda, Alejandro
Aguilar, Mariela C
Relhan, Nidhi
Flynn, Harry W
Amescua, Guillermo
Parel, Jean-Marie
Alfonso, Eduardo
author_facet Peterson, Jeffrey C
Durkee, Heather
Miller, Darlene
Maestre-Mesa, Jorge
Arboleda, Alejandro
Aguilar, Mariela C
Relhan, Nidhi
Flynn, Harry W
Amescua, Guillermo
Parel, Jean-Marie
Alfonso, Eduardo
author_sort Peterson, Jeffrey C
collection PubMed
description PURPOSE: To characterize the molecular, epidemiological, and resistance profiles of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) keratitis isolates. PATIENTS AND METHODS: We used a combination of standard microbiological techniques and DNA microarray analysis to characterize the molecular and antibiotic resistance profiles of 75 Staphylococcus aureus keratitis isolates collected over an 11-year period (2006–2016). RESULTS: Two major USA clonal complexes (CC), CC5 (n=30, 40%) and CC8 (n=28, 37.3%), accounted for 77.3% of the collected S. aureus isolates. USA100, traditionally healthcare associated (n=18/47, 38.3%), and USA300, traditionally community associated (n=12/47, 25.5%), were the dominant MRSA strains. Four (22.2%) of the USA100 MRSA isolates were recovered from patients with no prior healthcare exposure. Eleven (91.7%) of the USA300 isolates were recovered from patients with documented healthcare risk factors. MSSA isolates were polyclonal (n=13). Ninety-three percent of MSSA infections were of healthcare origin. Thirty-seven of 61 (60.6%) healthcare- and 11 of 14 (78.6%) community-associated strains were resistant to three or more antibiotic classes. Sixty-eight percent (n=51) of isolates harbored three of more resistance determinants (genes). The Panton-Valentine Leucocidin gene was detected in 11 (14.7%) of the study isolates. The majority (72.7%) of the strains were members of the USA300 MRSA clone. CONCLUSION: Clonal complexes CC5 and CC8 were the most frequent clones detected among both the MSSA and the MRSA keratitis isolates. USA100 and USA300 clones were the dominant MRSA genotypes. The USA300 MRSA clone has become a leading cause of healthcare-associated keratitis in South Florida. The USA100 MRSA clone has emerged as an increasing cause of community-associated corneal infections in our outpatient population. This shifting epidemiology coupled with the increasing prevalence of multidrug resistance among both MSSA and MRSA keratitis is a cause of concern.
format Online
Article
Text
id pubmed-6469469
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-64694692019-05-01 Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates Peterson, Jeffrey C Durkee, Heather Miller, Darlene Maestre-Mesa, Jorge Arboleda, Alejandro Aguilar, Mariela C Relhan, Nidhi Flynn, Harry W Amescua, Guillermo Parel, Jean-Marie Alfonso, Eduardo Infect Drug Resist Original Research PURPOSE: To characterize the molecular, epidemiological, and resistance profiles of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) keratitis isolates. PATIENTS AND METHODS: We used a combination of standard microbiological techniques and DNA microarray analysis to characterize the molecular and antibiotic resistance profiles of 75 Staphylococcus aureus keratitis isolates collected over an 11-year period (2006–2016). RESULTS: Two major USA clonal complexes (CC), CC5 (n=30, 40%) and CC8 (n=28, 37.3%), accounted for 77.3% of the collected S. aureus isolates. USA100, traditionally healthcare associated (n=18/47, 38.3%), and USA300, traditionally community associated (n=12/47, 25.5%), were the dominant MRSA strains. Four (22.2%) of the USA100 MRSA isolates were recovered from patients with no prior healthcare exposure. Eleven (91.7%) of the USA300 isolates were recovered from patients with documented healthcare risk factors. MSSA isolates were polyclonal (n=13). Ninety-three percent of MSSA infections were of healthcare origin. Thirty-seven of 61 (60.6%) healthcare- and 11 of 14 (78.6%) community-associated strains were resistant to three or more antibiotic classes. Sixty-eight percent (n=51) of isolates harbored three of more resistance determinants (genes). The Panton-Valentine Leucocidin gene was detected in 11 (14.7%) of the study isolates. The majority (72.7%) of the strains were members of the USA300 MRSA clone. CONCLUSION: Clonal complexes CC5 and CC8 were the most frequent clones detected among both the MSSA and the MRSA keratitis isolates. USA100 and USA300 clones were the dominant MRSA genotypes. The USA300 MRSA clone has become a leading cause of healthcare-associated keratitis in South Florida. The USA100 MRSA clone has emerged as an increasing cause of community-associated corneal infections in our outpatient population. This shifting epidemiology coupled with the increasing prevalence of multidrug resistance among both MSSA and MRSA keratitis is a cause of concern. Dove Medical Press 2019-04-11 /pmc/articles/PMC6469469/ /pubmed/31043797 http://dx.doi.org/10.2147/IDR.S190245 Text en © 2019 Peterson et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Peterson, Jeffrey C
Durkee, Heather
Miller, Darlene
Maestre-Mesa, Jorge
Arboleda, Alejandro
Aguilar, Mariela C
Relhan, Nidhi
Flynn, Harry W
Amescua, Guillermo
Parel, Jean-Marie
Alfonso, Eduardo
Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates
title Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates
title_full Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates
title_fullStr Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates
title_full_unstemmed Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates
title_short Molecular epidemiology and resistance profiles among healthcare- and community-associated Staphylococcus aureus keratitis isolates
title_sort molecular epidemiology and resistance profiles among healthcare- and community-associated staphylococcus aureus keratitis isolates
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469469/
https://www.ncbi.nlm.nih.gov/pubmed/31043797
http://dx.doi.org/10.2147/IDR.S190245
work_keys_str_mv AT petersonjeffreyc molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates
AT durkeeheather molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates
AT millerdarlene molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates
AT maestremesajorge molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates
AT arboledaalejandro molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates
AT aguilarmarielac molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates
AT relhannidhi molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates
AT flynnharryw molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates
AT amescuaguillermo molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates
AT pareljeanmarie molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates
AT alfonsoeduardo molecularepidemiologyandresistanceprofilesamonghealthcareandcommunityassociatedstaphylococcusaureuskeratitisisolates